scholarly journals Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial

2015 ◽  
Vol 34 (11) ◽  
pp. 1801-1817 ◽  
Author(s):  
Song Yang ◽  
Ross L. Prentice
Keyword(s):  
Clinical Trials ◽  
Hormone Therapy ◽  
Women's Health ◽  
Treatment Effect ◽  
Survival Data ◽  
Observational Studies ◽  
Time Dependent ◽  
Health Initiative ◽  
Therapy Trial ◽  
The Women’S Health Initiative

scholarly journals Impact of hormone therapy on Medicare spending in the Women’s Health Initiative randomized clinical trials

2018 ◽  
Vol 198 ◽  
pp. 108-114 ◽  
Author(s):  
Jacqueline B. Shreibati ◽  
JoAnn E. Manson ◽  
Karen L. Margolis ◽  
Rowan T. Chlebowski ◽  
Marcia L. Stefanick ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Hormone Therapy ◽  
Women’S Health ◽  
Women's Health ◽  
Randomized Clinical Trials ◽  
Women's Health Initiative ◽  
Women’S Health Initiative ◽  
Health Initiative ◽  
Medicare Spending ◽  
The Women’S Health Initiative

scholarly journals Admixture mapping of pelvic organ prolapse in African Americans from the Women’s Health Initiative Hormone Therapy trial

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0178839 ◽  
Author(s):  
Ayush Giri ◽  
Katherine E. Hartmann ◽  
Melinda C. Aldrich ◽  
Renee M. Ward ◽  
Jennifer M. Wu ◽  
...  
Keyword(s):  
Pelvic Organ Prolapse ◽  
African Americans ◽  
Hormone Therapy ◽  
Women's Health ◽  
Pelvic Organ ◽  
Admixture Mapping ◽  
Women's Health Initiative ◽  
Health Initiative ◽  
Therapy Trial ◽  
The Women’S Health Initiative

scholarly journals Estrogen Use and Breast Cancer Increases

2020 ◽  
pp. 1-2
Author(s):  
Ellen C G Grant ◽  
Ellen C G Grant
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Hormone Therapy ◽  
Women's Health ◽  
Women's Health Initiative ◽  
Women’S Health Initiative ◽  
Health Initiative ◽  
Follow Up Study ◽  
The Women’S Health Initiative

The Women’s Health Initiative (WHI) clinical trials 24-year follow-up study found increases in breast cancer and mortality with combined progestin/estrogen hormone therapy (HT) but reduced risks with estrogen-only HT [1]. The latter finding is dubious especially as HT use seems to be unknown during the long follow-up period [1].

Sign in / Sign up

Export Citation Format

Share Document